Cargando…

Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program

In this article, the authors show the strategy used to streamline the introduction of fexinidazole, the first all oral treatment of human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense. The dose range was determined in phase 1 studies and a significant food effect was observed,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valverde Mordt, Olaf, Tarral, Antoine, Strub-Wourgaft, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154641/ https://www.ncbi.nlm.nih.gov/pubmed/35292581 http://dx.doi.org/10.4269/ajtmh.21-1176

Ejemplares similares

Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies
por: Tarral, Antoine, et al.
Publicado: (2014)

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole
por: Neau, Philippe, et al.
Publicado: (2020)

Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study
por: Tarral, Antoine, et al.
Publicado: (2023)

Safety and efficacy of oral fexinidazole in children with gambiense human African trypanosomiasis: a multicentre, single-arm, open-label, phase 2–3 trial
por: Kande Betu Kumesu, Victor, et al.
Publicado: (2022)

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
por: Kande Betu Ku Mesu, Victor, et al.
Publicado: (2021)

Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
por: Bernhard, Sonja, et al.
Publicado: (2022)

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis
por: Pelfrene, Eric, et al.
Publicado: (2019)

Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole
por: Watson, James A., et al.
Publicado: (2019)

Discovery, Development, Inventions and Patent Review of Fexinidazole: The First All-Oral Therapy for Human African Trypanosomiasis
por: Imran, Mohd, et al.
Publicado: (2022)

Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo
por: Das, Aatreyee M., et al.
Publicado: (2021)

Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

Communities’ Perception, Knowledge, and Practices Related to Human African Trypanosomiasis in the Democratic Republic of Congo
por: Kabanga, Charlie, et al.
Publicado: (2022)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

How Clinical Research Can Contribute to Strengthening Health Systems in Low Resource Countries
por: Mbo, Florent, et al.
Publicado: (2020)

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
por: Betu Kumeso, Victor Kande, et al.
Publicado: (2023)

Treatment options for second-stage gambiense human African trypanosomiasis
por: Eperon, Gilles, et al.
Publicado: (2014)

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022)

The Burden of Human African Trypanosomiasis
por: Fèvre, Eric M., et al.
Publicado: (2008)

Chemotherapy of Human African Trypanosomiasis
por: Bacchi, Cyrus J.
Publicado: (2009)

Epidemiology of human African trypanosomiasis
por: Franco, Jose R, et al.
Publicado: (2014)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Fexinidazole interferes with the growth and structural organization of Trypanosoma cruzi
por: Zuma, Aline Araujo, et al.
Publicado: (2022)

Towards the Atlas of human African trypanosomiasis
por: Cecchi, Giuliano, et al.
Publicado: (2009)

Generation of neuroinflammation in human African trypanosomiasis
por: Rodgers, Jean, et al.
Publicado: (2019)

The history of African trypanosomiasis
por: Steverding, Dietmar
Publicado: (2008)

Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis
por: Nagle, Advait S., et al.
Publicado: (2014)

An approach to the development of new drugs for African trypanosomiasis
Publicado: (1978)

Fexinidazole: A Potential New Drug Candidate for Chagas Disease
por: Bahia, Maria Terezinha, et al.
Publicado: (2012)

Human African Trypanosomiasis in Areas without Surveillance
por: Chappuis, François, et al.
Publicado: (2010)

Immunophenotypic Lymphocyte Profiles in Human African Trypanosomiasis
por: Boda, Caroline, et al.
Publicado: (2009)

Urban Transmission of Human African Trypanosomiasis, Gabon
por: Simon, Fabrice, et al.
Publicado: (2012)

Human African trypanosomiasis control: Achievements and challenges
por: Aksoy, Serap, et al.
Publicado: (2017)

Kynurenine Pathway Activation in Human African Trypanosomiasis
por: Sternberg, Jeremy M., et al.
Publicado: (2017)

Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis
por: Kennedy, Peter G. E., et al.
Publicado: (2019)

Genetic and immunological basis of human African trypanosomiasis
por: Pays, Etienne, et al.
Publicado: (2021)

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis
por: Barrett, Michael P.
Publicado: (2018)

African Trypanosomiasis Gambiense, Italy
por: Bisoffi, Zeno, et al.
Publicado: (2005)

The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases
por: Simarro, Pere P, et al.
Publicado: (2010)

Evaluation of Antigens for Development of a Serological Test for Human African Trypanosomiasis
por: Biéler, Sylvain, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uocol4kl1p8iqd1ab7atr4nmpe